Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If it for some reason dips again I will increase the position two fold. 2016 will be amazing with this stock. I know that most OTC's are flips, this is an obvious hold.
Or you could just "bail" to another board. Or maybe put in some valid input.
What is fishy?
We were green all day, Ticker Error on the%
For the past several years, China has been hailed as the "next big thing" in consumerism. Its population is huge, but has only recently become capable of spending in a way that mirrors the spending habits of western consumers. That internal consumption - rather than exports - has given rise to a whole new era of economic growth in China, and the country's weaker GDP growth rates are still better than the best GDP growth rates the United States or Europe could boast.
The increasing westernization of China, though, has underscored some key challenges as well as key opportunities for the giant country. One of the biggest, overarching hurdles is the simple fact that China doesn't have enough clean water; people living in rural area now know just how bad this problem is, having realized it using their internet connections, many of which are mobile connections.
The statistics: China holds only 7% of the world's fresh water supply, but 20% of the world's population calls the country home.
And yet, the rise of the consumer class in China that made it clear the country has a water-shortage problem also, ironically, has made the clean water shortage problem worse, as the rise of heavy-polluting factories supply the jobs that have made so many Chinese citizens more well-off than they were in the past.
The nation's government says it's working toward quelling its rampant pollution, though its enforcement of tough regulations to that end has been hit and miss. More often than not, the country has been opting to clean the water it has rather than finding a way of not dirtying it in the first place.
And the initiatives have been bold, even if odd. As an example, the country's government has backed some experimenting with so-called sponge cities, which handle water that most of the nation's urban areas simply can't any longer. Though the primary intent is to divert water away from major urban infrastructure, it's also got a water-scrubbing aspect to it. Project coordinator Kongjian Yu explains "A sponge city is one that can hold, clean, and drain water in a natural way using an ecological approach."
China deserves credit for a creative approach, but sponge cities are more of a philosophical approach where applied, practical, and literal solutions are needed. They're also expensive, at about $180 million per project. That's where an up-and-coming company called Cardinal Resources Inc. (OTCBB:CDNL).
Cardinal Resources has developed a ground-breaking water purification technology and platform that fills the important market between 5000 and 20,000 people. Anything less, and personal systems like the "drinkable book" and hand-held filtration systems make more sense. Anything more, and utility-scale water systems become prudent. There are thousands of small communities all over the world, however, that are trapped in the middle... with a sizeable need, but not the funding necessary to make permanent potable water a long-term reality.
The solution Cardinal Resources brings to the table is called a Red Bird System. Though the company makes various-sized systems to meet different needs, they're all about the size of a concession stand. A couple of them are mobile, capable of being towed by a small truck.
Depending on the equipment in question, a system can clean anywhere from 50,000 liters to more than 200,000 liters per day (between 10 and 40 gallons per minute), which is enough to serve communities of between 5000 and 20,000 people, respectively. Better still, these systems require no infrastructure , no nasty chemicals, and no constant changing of filters; the only filter to speak of on a Red Bird system needs to be replaced once every five years.
At a price of anywhere between $125,000 and $270,000 per system (mostly depending on its size and capacity), some would-be buyers can easily afford the equipment, while others can't. CDNL doesn't have to sell these systems to make money though. It can sell the water it cleans to achieve a nice ROI on the technology, which doesn't force a community in need to come up with a great sum of money right up front. Or, Cardinal Resources also offers lease-to-own options. Joint ventures and co-ops - both private and public - are also in the works.
More important right now, China is finally tapping into this practical solution that Cardinal Resources offers.
Earlier this week, the HangZhou Sky Valley Water Technology Co. - a China-based consortium formed to market and commercialize Cardinal Resources' water treatment technologies in Asia and other international markets - ordered one of these systems, and is planning on buying two more as part of just its initial order.
It was actually a relationship that was quietly forged back on October 13th, when CDNL raised several million dollars worth of funding by selling 51% of itself to this Chinese consortium that didn't just want an investment in a novel idea, but also wanted to build a joint venture that would distribute Red Bird Systems in China. It was the first and last investors heard of it until Monday. Now, that partner/investor has ramped up that relationship by becoming a customer.
The exciting part is, the clean water market in China is a $29 billion opportunity. Odds are good this is just the first of many Red Bird Systems China will want. It's a far more practical approach, and will certainly solve the problems in rural areas where a sponge city would have to impact whatsoever.
http://www.smallcapnetwork.com/Cardinal-Resources-Offers-a-Real-and-Real-Quick-Solution-to-the-Clean-Water-Shortage-in-China/s/via/1789/article/view/p/mid/1/id/630/
Ladies and gentleman, please head over to the CDNL board for further posting. Negligent financial "e" has been lifted.
Happy it's back, too bad it's not really at .85, that would be fantastic.
The book value is there, this one is really just waiting for the PR, as we all know could go either way, but without it it's gonna ride the lows. Hell its otc could run or crash for no reason.
Welcome to the board, you won't be disappointed. News any day now, with financial.
Agree, but when it goes it will go quickly
I was tracking closer to 35 mil.
Premier Biomedical Receives Notice of Allowance on Broad Base Patent Involving Innovative Extracorporeal Treatment Therapy – Premier Believes This May Lead To Cancer Cure
Posted at November 16, 2015 | By : Admin | Categories : Investor News,News,Press Releases,Uncategorized | 0 Comment
EL PASO, TX – November 16, 2015 – Premier Biomedical, Inc. (OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as potential novel therapies for neurofibromatosis, atherosclerosis and muscular dystrophy, announced today they have obtained exclusive rights to the recently allowed U.S. patent application, “Sequential Extracorporeal Treatment of Bodily Fluids”, covering the basic technology underpinning Premier’s on-going research into new, innovative treatments for many of today’s most debilitating diseases.
Premier Biomedical, Inc. is developing a methodology for treating multiple diseases, such as cancer, which is completely different from the standard treatments now being utilized. The vast majority of presently known treatments directly inject possibly harmful agents into the body of a patient. This presents a very real risk of adverse side effects from the treatment.
Premier Biomedical, Inc. intends to develop its proprietary methodology in which the pathologies are eradicated by sequentially dialyzing the patient’s blood extracorporeally (outside the body). The method will utilize designer antibodies to physically remove the pathophysiologic basis of the disease. For example, in cancer treatment, there will be the physical attachment and removal of metastasizing cancer cells, proteins or molecules which are responsible for the development, progression and metastasis of the disease. This extracorporeal methodology has an enormous potential for dramatically decreasing any side effects in the treatment of ill patients. The estimated expenditures for cancer treatment in the U.S. in 2010 were approx. $124.5 Billion, and projected to rise to $158 – $175 Billion by 2020[1].
William A. Hartman, CEO and President of Premier Biomedical, stated that, “Between this sequential extracorporeal therapy patent just granted, and the previously granted patent Utilization of Stents for the Treatment of Blood Borne Carcinomas (US Patent 8,758,287: 6/24/14), I believe that we have a clear roadmap for potentially curing cancer, possibly at any stage, and even after extensive metastasis. These patents support our on-going experimentation and plans to present our stunning results to the American Association for Cancer Research (AACR) in December.” Mr. Hartman can be contacted via email at w.hartman@premierbiomedical.com or by phone at (PBI) MED-7033 / (724) 633-7033.
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (OTCQB: BIEI) is a research-based publicly traded company that intends to discover and develop medical treatments for a wide range of diseases in humans. Premier has licensed the technology behind multiple provisional patents in the United States and a PCT Europe National Patent. Founded in 2010, Premier has partnered with the Department of Defense with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP). The company’s R&D efforts are centered in El Paso, TX, and their business offices are in Western Pennsylvania. The Company is a fully-reporting issuer whose common stock trades on the OTCQB marketplace maintained by OTC Markets Group, Inc. under the ticker symbol “BIEI.” http://www.premierbiomedical.com/. For more information please contact: William A. Hartman, President and CEO, Premier Biomedical Inc., at (724) 633-7033 or via email w.hartman@premierbiomedical.com
http://www.premierbiomedical.com/premier-biomedical-receives-notice-of-allowance-on-broad-base-patent-involving-innovative-extracorporeal-treatment-therapy-premier-believes-this-may-lead-to-cancer-cure/
GDSI acquires Brazil-based Rontan Group
GDSI has announced that it has acquired the Rontan Group ("Rontan"), headquartered in Sao Paulo state, Brazil. At an upcoming special meeting, GDSI's board of directors is expected to elect Rontan's CEO, Edigimar A. Maximiliano Jr., Chief Executive Officer of GDSI and Richard J. Sullivan Non-Executive Chairman.
Founded in 1970, privately held Rontan designs, manufactures and delivers emergency warning equipment specifically for public safety organizations and professionals. Rontan exports products to many of the world's most competitive markets, including the United States, Canada, Central and South America, Europe, Asia, Australia, Middle East and Africa. The largest specialty vehicles and acoustic and visual signaling equipment company in Latin America, Rontan has earned ISO and TS Certifications, attesting to the quality of its management systems.
With 2014 revenue of R$ 500 million (approximately US$ 128 million), Rontan produces some 5,000 vehicles per month and has approximately 1,200 direct and indirect employees. In 1999, through a partnership with the biggest worldwide manufacturers of vehicles for fire fighters, Rontan became an authorized representative of the Oshkosh Pierce vehicles.
Rontan Telecom is the largest manufacturer and distributor of Motorola radios and communication trunking systems for police forces in Brazil, providing technical assistance on the full line of Motorola radios.
"This exciting transaction represents a significant step forward for GDSI," said Richard J. Sullivan, expected to be named non-executive Chairman of GDSI. "We have been extremely impressed by Rontan's 45 years of experience and exceptional record of serving customer needs with top-quality products and services – both in Brazil and internationally. Rontan's capabilities create enormous synergies with the specialty vehicles produced by North American Custom Specialty Vehicles (NACSV), GDSI's wholly-owned subsidiary. We're especially delighted that "Max" Maximilliano (Rontan's CEO, Edigimar A. Maximilliano) will serve as GDSI's CEO. Max is an extremely talented and experienced leader, and we're excited about welcoming Max and the entire Rontan team to the growing GDSI family."
"This is a momentous milestone in Rontan's 45-year history," said Edigimar Maximilliano ("Max"), expected to be named GDSI's new CEO. "The combination of Rontan and GDSI – with GDSI's experienced management team and board of directors headed by Richard Sullivan – will help us expand our capabilities while continuing to provide our worldwide customers with world-class products and services. I'm looking forward to leveraging Rontan's extensive experience and international reach to enable the new GDSI team to seize the many profitable growth opportunities envisioned by GDSI's global strategy."
Refer to GDSI's October 19, 2015, 8-K filing for more details about this transaction
http://www.gdsi.co/
Date Price High Low Volume
12/1/2015 0.52 0.60 0.49 1,058,821
11/30/2015 0.55 0.59 0.40 1,523,662
11/27/2015 0.42 0.43 0.38 364,864
11/25/2015 0.40 0.40 0.38 463,300
11/24/2015 0.40 0.40 0.35 535,631
11/23/2015 0.36 0.40 0.32 597,963
11/20/2015 0.35 0.43 0.34 1,156,168
11/19/2015 0.42 0.49 0.40 1,375,765
11/18/2015 0.43 0.44 0.36 1,616,489
11/17/2015 0.38 0.39 0.28 2,589,461
11/16/2015 0.26 0.36 0.24 2,608,491
11/13/2015 0.37 0.46 0.36 1,067,469
11/12/2015 0.45 0.55 0.39 1,365,314
11/11/2015 0.41 0.45 0.21 2,801,016
11/10/2015 0.47 0.57 0.45 1,055,973
11/9/2015 0.50 0.92 0.39 3,616,252
11/6/2015 0.93 0.93 0.86 258,272
11/5/2015 0.88 0.93 0.85 203,279
11/4/2015 0.89 0.93 0.86 429,408
11/3/2015 0.87 0.94 0.81 590,064
11/2/2015 0.83 0.85 0.72 435,716
10/30/2015 0.76 0.80 0.71 328,608
10/29/2015 0.78 0.85 0.76 516,126
10/28/2015 0.85 0.90 0.76 1,122,632
10/27/2015 0.75 0.95 0.72 1,559,198
10/26/2015 0.95 1.04 0.90 594,481
10/23/2015 1.01 1.07 0.98 671,408
10/22/2015 1.02 1.14 0.96 1,038,707
10/21/2015 1.12 1.16 1.05 623,132
10/20/2015 1.08 1.26 1.07 1,103,418
10/19/2015 1.23 1.50 1.13 1,352,061
10/16/2015 1.18 1.21 1.11 651,926
10/15/2015 1.17 1.17 1.05 713,406
10/14/2015 1.14 1.19 1.13 543,173
10/13/2015 1.19 1.23 1.10 670,318
10/12/2015 1.13 1.24 1.11 613,356
10/9/2015 1.19 1.25 1.11 941,672
10/8/2015 1.11 1.13 1.06 500,178
10/7/2015 1.10 1.20 1.03 1,441,844
10/6/2015 1.17 1.20 1.05 1,864,575
10/5/2015 1.04 1.07 0.84 2,627,723
10/2/2015 0.85 0.90 0.79 901,671
10/1/2015 0.85 0.92 0.81 1,216,046
Good post about a great company Ice, this stock is not for the flippers, I'm in it for the long, because it's not like the others that fluff their information, the company keeps up informed and like you mentioned there is plenty of upside.
Me too, it will get filed. The price will go up and hopefully the merger will go through. The are OTC's people that want to make millions are crazy take profits and ride the waves.
I believe that .06 to .07 is a good short term prediction.
It all depends on the PR and News, the financials are out and "if" they move forward with their drug it will run. There are a lot of new people on the board hyping it up but the DD has been done at this point its up to the company to see where it will go, I have already made a lot of money off of this stock getting in at low double 0's so looking forward to another good run.
Mr. Jones is making his goals come true, all the news that is about to hit can make ours too. I know it sounds corny but get in why you can.
•Mr. Jones founded Cardinal Resources in 2004 as a double bottom line company with the goals to build a global company focused on the mission of Clean Water - Clean Environment - Worldwide.Beginning with conceptual designs in 2005, Mr. Jones has been instrumental in the development of the Red Bird System and holds four patents relative to the multimedia filtration and the system itself. ?Through Mr. Jones’ efforts, in 2011 Cardinal Resources was recognized by Commercial News USA as the Exporter of the Year in the Environmental Category and also received an Export Achievement Award from US Commercial Services (USCS). This growth and commitment has also generated international investments in late 2013 into the company from five countries.
You still have the opportunity, this thing is low enough to make a lot of us rich still. The financials will be out within 10 days and pushing .10 with that. IMO
Money in the making. Not much longer.
Most definitely blue
Buy on the dips ladies and gent's the financials will be released soon. The "E" will be dropped and business will boom.
I believe it was initially due to a rough year of financials.
.028 with a close of .036
Trading in the Pre-Market, hoping for another good day.
It should be minimized. The possibilities of this stock are in the hands of the company, they need to show positive ventures in their investments and the financials will sky rocket. The downward pressure would have been caused by lack of revenue. The volume available to trade is still there, the O/S and float have room but a good squeeze and it takes off.
Come to the current board at CDNLE, you'll have more conversation.
This team has always been upfront and honest.
Management Team
Kevin R. Jones
President
Barbara H. Jones
Executive Vice President
Joyce M. O’Connor, P.G.
Vice President of Technology Development
Christine McGaughey
Marketing and Operations
The Solution - Clean water with only sun and salt
The patented Red Bird System is a game-changing approach for bringing clean water to underserved communities around the world.
People around the world know the value of safe water
There is demand for safe, clean water in both developing and middle-income countries
Our solar-powered water treatment system is a groundbreaking, ruggedized high-tech solution for low-tech environments. The Red Bird System produces tens of thousands of gallons of clean water daily from any fresh water (non-saline) source at a fraction of a cent per gallon. We train local people to maintain and operate the systems, so that safe water will be sustainable for years to come. Clean, great tasting drinking water and local jobs - all part of the Red Bird System.
Training for installation, operation, and water quality testing
What makes Red Bird Systems unique?
The Red Bird System succeeds where other approaches have not because of unique technology, integration with quality components, and technical support:
During this Red Bird demonstration, women couldn’t wait to sample clean water for their families
Its high output produces enough water for a community.
Automation and controls provide many safeguards for water quality and safety.
Automation for control and safety
The Red Bird System has an integrated pump to take water from the source, granular filters that last for years, on-site chlorine generation, and can pump water to a storage tank up to 30 feet high.
Placing the integrated pump into the source of water to be treated
It is solar-powered and has battery storage so that it can operate through the night.
Battery storage for operation when the sun isn’t shining
Alternatively, it can be operated from a generator or grid power.
Its only routine supplies are rock salt to make up the brine for chlorine generation, and vinegar to clean the chlorine electrode.
To accommodate various communities, we have developed three different Red Bird Systems:
Mobile Red Bird System
Community Red Bird System - 10
Community Red Bird System - 20
Click here to see videos of the Red Bird System in action.
Notes:
1Contact Cardinal Resources to find the best system and water production for your site.
2Cardinal Resources can change the look of the system to match your needs! Contact us for details.
http://www.cardinalres.com/red-bird/overview
I wouldn't worry about the "E", They have to be taking longer getting it together for the huge revenue they are adding up. More contracts to come and future PR to send this through the roof.
Yes sir, I was strictly using it as an example, I'm not on the train at all, At least ELTP has a product. This product is the future of pain management. I also like that the CEO realizes the size of his company and is not trying to take on the giants, just as he said, "ride the coat tail". Best method for this company.
I completely agree Vrock, I don't think that it will be anything as crazy as Kb*o but the shorts will yet again learn a tough lesson.
Once financials are released this is going to be time for facts. Looking forward to it.
Not new news here, but good info. Potential on the rise, disregard all of the haters. Once we hit .05 we will have one less hater on the board. Soon!!
Tourism
•Major hotel brands have business terms agreed to start in Cape Verde due to the high occupancy rates of over 90%.
•Tourism numbers increased by 1550% in the last 15 years.
•Country growth will be heavily reliant upon the tourism sector.
•Forecasts for the next 10 years are for average annual growth rates of between 6% and 10% per annum to reach 1 million visitors. (White Bridge Hospitality 2011)
•Cabo Verde was listed 3rd in BBC’s ‘Lonely Planet 2011’ top destination guide.
•The port of São Vicente island will have a 19.8 million Euro investment to cater for Cruise Ships up to 309 meters. This pier will handle up to 148.000 passengers per annum.
•Cabo Verde and São Vicente in particular is poised to emerge further as a truly international high-end luxury resort destination.
•Wall Street Journal Market Watch announced Cabo Verde as top 10 mid-haul destination for 2011.
http://www.caboverdecapital.com/investors/tourism-flights/
Success stories:
- Riu Funana, Sal Island 500 rooms
- Riu Garopa, Sal Island 500 rooms
- Riu Karamboa, Boa Vista Island 750 rooms
- Riu Touareg, Boa Vista Island 881 rooms
- Sol Melia Tortuga, Sal Island 221 rooms
Sol Melia has 3 further resorts under project in Cabo Verde.
Occupancy rates of over 90% are achieved on average.
•The number of tourists that stayed in Cape Verde’s hotels in 2012 totalled 534,000 and for the first time exceeded the total population of the archipelago, which is estimated at 497,000 people.
•INE said that the number of guests in 2012 rose by 12.3 percent against 2011 and the United Kingdom was the source of the largest number of tourists.
•UK visitors, which accounted for 21.6 percent of the total, were followed by those from France (13 percent), Portugal (12.7 percent) and Germany (12.6 percent)
Not a new update but still good information, did anyone here by chance attend the conference call back on the 10th?
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016
Webcast and Conference Call Scheduled for Tuesday, November 10th at 11:00 AM EST
NORTHVALE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second quarter of its 2016 fiscal year.
Consolidated revenues for the second quarter of Fiscal 2016 were $2.7 million, a 115% increase on a year-on-year basis. The increase in revenues is due to the continued growth of Elite's niche generic product lines. During the quarter, Elite invested an additional $4.2 million in the development of ELI-200, the first product in Elite's line of abuse-deterrent opioids.
In October, Elite announced positive top-line results from the Phase 3 pivotal trial of its lead abuse-deterrent opioid, ELI-200, for the treatment of moderate to severe pain. The Company is on schedule to file a New Drug Application with the U.S. Food and Drug Administration later this year. Elite will provide an update of development activities during the conference call.
"Another outstanding quarter. Our generic products set another revenue record, and we successfully completed Phase 3 trials for ELI-200," commented Nasrat Hakim, President and CEO of Elite. "Elite has never been stronger as we steadily move towards the filing of ELI-200 this year, the expected launch next year and the continued development of a range of abuse deterrent opioids."
About Elite's Abuse Deterrent Technology
Elite's proprietary abuse deterrent technology, ART™, is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases as intended providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed or dissolved, the opioid antagonist is designed to release and so block the effects of active opioid agonist. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to the same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers. Elite's pharmacological approach to abuse-deterrence can be applied to a wide range of opioids used today in pain management.
Conference Call Information
Elite's management will host a conference call to discuss the results of operations and provide an update on recent business developments: Company executives will conduct a question and answer session following their remarks.
Date: Tuesday, November 10, 2015
Time: 11:00 a.m. EST
Webcast (live and archive) & Audio Replay: http://ir.elitepharma.com/events_presentations
http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=79776&BzID=2258&t=1948&g=939&Nav=0&LangID=1&s=0
Just hoping this movement isn't because of the 8k, need some good financial news.
Where is the "like" button. lol
If you have News try providing a link, if not it makes you look like you're just trying to pump it. We need newbies to have confidence, not think that its fluff.
I'm a hold you too that!